Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000027

Chief Operating Officer sold 100 shares at $15.01 ($1,501)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2022-09-15 Sale −100 $15.01 $1,501 68,648 D: show line 1 in the form
Open-market sales · 100 sh · avg $15.01 · $1,501
Loading xslF345X03/wf-form4_166361963989994.xml…